Why an Open, Standards-Based Approach is Essential for the Pharma Supply Chain
A proven partner or just a vendor? Your investment in serialization should set you on a path to create transformational value for your business. With a trusted partner, this is possible. Understand the importance of an open, standards-based approach and the five critical questions you should ask to ensure you choose a proven partner with expertise to guide you, and not just a vendor.
TraceLink Appoints Former Merck KGaA Thought Leader to Drive Analytics Strategy
Bharath Sundararaman will utilize analytics, artificial intelligence, and machine learning to unlock value from digital supply network data to improve drug safety and availability for patients.
DSCSA Saleable Returns Enforcement Discretion; A Letter from TraceLink’s CEO
The FDA has announced a 12-month delay in enforcement action for the DSCSA saleable returns verification requirement applicable to wholesale distributors but not to manufacturers. What does this mean for the industry? In an open letter, TraceLink’s President and CEO, Shabbir Dahod, shares his insights.